Sloan-Kettering was outraged by the FDA and AMA’s cover-up of B17, and for five years, studies were conducted by Sloan on the anti-cancer benefits of B17 which found that:
1. It improved the overall health of cancer patients.
2. It acted as a preventative measure against cancer.
3. It stops the spread of cancer in mice.
continued on the next page
ADVERTISEMENT
